NCT00140218View on ClinicalTrials.gov

R(+) Pramipexole in Early Amyotrophic Lateral Sclerosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

December 31, 2006

Conditions
Amyotrophic Lateral Sclerosis
Interventions
DRUG

R(+) pramipexole dihydrochloride monohydrate

10 mg tid oral

Trial Locations (2)

22908

University of Virginia, Charlottesville

Unknown

David Lacomis MD, Pittsburgh

All Listed Sponsors
collaborator

University of Pittsburgh

OTHER

lead

Bennett, James P., Jr., M.D., Ph.D.

INDIV

NCT00140218 - R(+) Pramipexole in Early Amyotrophic Lateral Sclerosis | Biotech Hunter | Biotech Hunter